⌘K

Login Start Free

Home/Filings/4/0001062993-23-004533

4//SEC Filing

Smeykal Megan 4

Accession 0001062993-23-004533

CIK 0001561921other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:10 PM ET

Size

4.6 KB

Accession

0001062993-23-004533

Insider Transaction Report

Form 4

Period: 2023-02-21

TELA Bio, Inc.TELA

Chief Accounting OfficerOther

Transactions

Award
Common Stock
2023-02-21+9,400→ 21,489 total

Footnotes (1)

[F1]These restricted stock units will vest in four equal annual installments beginning on February 21, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1

filerCIK 0001899973

Filing Metadata

Form type: 4
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 4:10 PM ET
Size: 4.6 KB

View on SEC.gov